U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 742

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr13:32905048
GRCh38:
Chr13:32330911
BRCA2Neoplasm of ovaryUncertain significance
(Sep 30, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr2:47641498
GRCh38:
Chr2:47414359
MSH2D229Y, D295YNeoplasm of ovary, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Jul 7, 2022)
criteria provided, conflicting interpretations
3.
GRCh37:
Chr3:41275805
GRCh38:
Chr3:41234314
CTNNB1, LOC126806659Pilomatrixoma, Exudative vitreoretinopathy 7, Neoplasm of ovary,
Colorectal cancer, Medulloblastoma, Severe intellectual disability-progressive spastic diplegia syndrome,
Hepatocellular carcinoma, not provided
Benign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr3:41275676
GRCh38:
Chr3:41234185
CTNNB1, LOC126806659H517R, H524Rnot provided, Severe intellectual disability-progressive spastic diplegia syndrome, Hepatocellular carcinoma,
Colorectal cancer, Pilomatrixoma, Exudative vitreoretinopathy 7,
Neoplasm of ovary, Medulloblastoma
Uncertain significance
(Nov 26, 2021)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr6:162475190
GRCh38:
Chr6:162054158
PRKND184VLung cancer, Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2,
not provided
Uncertain significance
(Sep 13, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr6:162864440
GRCh38:
Chr6:162443408
PRKNQ25*Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer,
not provided
Pathogenic/Likely pathogenic
(May 26, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr6:162683814-162683815
GRCh38:
Chr6:162262782-162262783
PRKNnot provided, Lung cancer, Autosomal recessive juvenile Parkinson disease 2,
Neoplasm of ovary
Benign
(Sep 22, 2021)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr16:68849589
GRCh38:
Chr16:68815686
CDH1D437N, D498Nnot provided, Familial cancer of breast, Blepharocheilodontic syndrome 1,
Endometrial carcinoma, Hereditary diffuse gastric adenocarcinoma, Neoplasm of ovary,
Malignant tumor of prostate, Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma
Uncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr17:41246352-41246353
GRCh38:
Chr17:43094335-43094336
BRCA1Familial cancer of breast, Neoplasm of ovaryPathogenic
(Mar 19, 2021)
no assertion criteria provided
10.
GRCh37:
Chr11:108098332-108236255
ATMAcquired polycythemia vera, Endometrial serous adenocarcinoma, Neoplasm of ovary
Pathogenic
(Mar 19, 2021)
no assertion criteria provided
11.
GRCh37:
Chr17:7577127
GRCh38:
Chr17:7673809
TP53E112*, E139*, E232*, E271*Hereditary cancer-predisposing syndromePathogenic
(Aug 1, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr6:162683750
GRCh38:
Chr6:162262718
PRKNNeoplasm of ovary, Lung cancer, Autosomal recessive juvenile Parkinson disease 2,
not provided
Likely benign
(Apr 8, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr17:7572991
GRCh38:
Chr17:7669673
TP53K214fs, K241fs, K334fs, K373fsLi-Fraumeni syndromeUncertain significance
(May 13, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr17:33433407
GRCh38:
Chr17:35106388
RAD51D, RAD51L3-RFFLQ192*, Q212*, Q80*Hereditary cancer-predisposing syndromePathogenic
(Nov 10, 2020)
criteria provided, single submitter
15.
BRCA1Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
16.
BRCA1Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
17.
GRCh37:
Chr16:23646869
GRCh38:
Chr16:23635548
PALB2T333NNeoplasm of ovary, Familial cancer of breastUncertain significance
(Oct 7, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr6:162683616
GRCh38:
Chr6:162262584
PRKNG118Anot provided, Neoplasm of ovary, Lung cancer,
Autosomal recessive juvenile Parkinson disease 2
Uncertain significance
(Feb 14, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr17:56774284
GRCh38:
Chr17:58696923
RAD51CNeoplasm of ovaryUncertain significance
(Jan 29, 2012)
no assertion criteria provided
20.
GRCh37:
Chr6:161771010
GRCh38:
Chr6:161349978
PRKNLung cancer, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary,
Autosomal recessive juvenile Parkinson disease 2
Uncertain significance
(Nov 18, 2021)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr6:161770991
GRCh38:
Chr6:161349959
PRKNLung cancer, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary,
Autosomal recessive juvenile Parkinson disease 2
Uncertain significance
(Sep 3, 2021)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr6:162683722
GRCh38:
Chr6:162262690
PRKNT83ANeoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2, Lung cancer,
not provided, Autosomal recessive juvenile Parkinson disease 2
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr6:162683593-162683632
GRCh38:
Chr6:162262561-162262600
PRKNP113fsAutosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary,
Lung cancer, not provided
Pathogenic/Likely pathogenic
(Mar 22, 2023)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr17:56770067-56770068
GRCh38:
Chr17:58692706-58692707
RAD51CV25fsFanconi anemia complementation group OPathogenic
(Jan 12, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr3:41274905
GRCh38:
Chr3:41233414
CTNNB1not provided, Neoplasm of ovary, Colorectal cancer,
Pilomatrixoma, Exudative vitreoretinopathy 7, Severe intellectual disability-progressive spastic diplegia syndrome,
Medulloblastoma, Hepatocellular carcinoma
Benign/Likely benign
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr6:162683693
GRCh38:
Chr6:162262661
PRKNnot provided, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary,
Lung cancer
Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr6:162394354
GRCh38:
Chr6:161973322
PRKNnot provided, Autosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary,
Lung cancer
Benign/Likely benign
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr6:162206838
GRCh38:
Chr6:161785806
PRKNAutosomal recessive juvenile Parkinson disease 2, Neoplasm of ovary, Lung cancer,
not provided
Likely benign
(Jun 22, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr6:162206876
GRCh38:
Chr6:161785844
PRKNY239H, Y118H, Y267HLung cancer, Neoplasm of ovary, Autosomal recessive juvenile Parkinson disease 2,
not provided
Uncertain significance
(Dec 3, 2021)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr17:41243779-41243797
GRCh38:
Chr17:43091762-43091780
BRCA1, LOC126862571C1204fs, C1251fs, C1123fs, C1139fs, C1162fs, C1183fs, C1225fs, C1083fs, C1181fs, C1210fs, C1124fs, C1163fs, C1184fs, C1203fs, C1209fs, C1250fs, C955fs, C1140fs, C1180fs, C1224fs, C1248fs, C383fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
31.
GRCh37:
Chr13:32893345-32893363
GRCh38:
Chr13:32319208-32319226
BRCA2R67fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
32.
GRCh37:
Chr13:32911694-32911737
GRCh38:
Chr13:32337557-32337600
BRCA2V1068fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
33.
GRCh37:
Chr17:41245693
GRCh38:
Chr17:43093676
BRCA1H619fs, H572fs, H451fs, H549fs, H571fs, H592fs, H593fs, H492fs, H507fs, H508fs, H552fs, H578fs, H323fs, H530fs, H531fs, H551fs, H577fs, H616fs, H618fs, H491fs, H548fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
34.
GRCh37:
Chr2:48023149-48023157
GRCh38:
Chr2:47796010-47796018
MSH6Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
35.
GRCh37:
Chr5:56167842
GRCh38:
Chr5:56872015
MAP3K1H470fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
36.
GRCh37:
Chr10:89692974-89692975
GRCh38:
Chr10:87933217-87933218
PTENY155fs, Y328fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
37.
GRCh37:
Chr2:48027223-48027224
GRCh38:
Chr2:47800084-47800085
MSH6L571fs, L399fs, L701fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
38.
GRCh37:
Chr17:59820374
GRCh38:
Chr17:61743013
BRIP1Q793HNeoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
39.
GRCh37:
Chr13:32913385-32913428
GRCh38:
Chr13:32339248-32339291
BRCA2S1632fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
40.
GRCh37:
Chr10:89653804
GRCh38:
Chr10:87894047
PTENM35fs, M208fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
41.
GRCh37:
Chr17:7578478-7578480
GRCh38:
Chr17:7675160-7675162
TP53P20fs, P113fs, P152fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
42.
GRCh37:
Chr17:7577522
GRCh38:
Chr17:7674204
TP53I122fs, I254fs, I215fs, I95fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
43.
GRCh37:
Chr17:7576913
GRCh38:
Chr17:7673595
TP53N179fs, N311fs, N152fs, N272fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
44.
GRCh37:
Chr17:7579592
GRCh38:
Chr17:7676274
TP53Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
45.
GRCh37:
Chr17:7578493
GRCh38:
Chr17:7675175
TP53W107*, W14*, W146*Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Pathogenic
(Sep 7, 2023)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr17:7579361
GRCh38:
Chr17:7676043
TP53F109C, F70CNeoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
47.
GRCh37:
Chr17:7576865-7576866
GRCh38:
Chr17:7673547-7673548
TP53Y168fs, Y195fs, Y327fs, Y288fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
48.
GRCh37:
Chr17:7577029-7577030
GRCh38:
Chr17:7673711-7673712
TP53S171fs, S303fs, S264fs, S144fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
49.
GRCh37:
Chr17:7574030-7574031
GRCh38:
Chr17:7670712-7670713
TP53I293fs, I173fs, I200fs, I332fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
50.
GRCh37:
Chr17:7574024-7574055
GRCh38:
Chr17:7670706-7670737
TP53Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
51.
GRCh37:
Chr17:7578475
GRCh38:
Chr17:7675157
TP53P152fs, P20fs, P113fsLi-Fraumeni syndromePathogenic
(Oct 10, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr17:7577130
GRCh38:
Chr17:7673812
TP53F138L, F231L, F270L, F111LHereditary cancer-predisposing syndrome, Li-Fraumeni syndromeConflicting interpretations of pathogenicity
(Jul 6, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr17:7579307
GRCh38:
Chr17:7675989
TP53Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
54.
GRCh37:
Chr17:7577141
GRCh38:
Chr17:7673823
TP53G266fs, G134fs, G227fs, G107fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
55.
GRCh37:
Chr17:7578385
GRCh38:
Chr17:7675067
TP53C50fs, C23fs, C182fs, C143fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
56.
GRCh37:
Chr17:7578189
GRCh38:
Chr17:7674871
TP53Y181*, Y220*, Y88*, Y61*Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
57.
GRCh37:
Chr17:7578534
GRCh38:
Chr17:7675216
TP53K132N, K93Nnot provided, Li-Fraumeni syndromePathogenic/Likely pathogenic
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr17:7577566-7577567
GRCh38:
Chr17:7674248-7674249
TP53N80*, N200*, N107*, N239*Li-Fraumeni syndromePathogenic
(Jun 18, 2021)
criteria provided, single submitter
59.
GRCh37:
Chr17:7578419
GRCh38:
Chr17:7675101
TP53E132*, E171*, E39*, E12*Li-Fraumeni syndromePathogenic
(Dec 16, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr17:7577570
GRCh38:
Chr17:7674252
TP53M105I, M198I, M237I, M78IHereditary cancer-predisposing syndromeLikely pathogenic
(Jan 14, 2020)
criteria provided, single submitter
61.
GRCh37:
Chr17:7578290
GRCh38:
Chr17:7674972
TP53Li-Fraumeni syndrome, Hereditary cancer-predisposing syndromePathogenic
(Nov 30, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:7578463
GRCh38:
Chr17:7675145
TP53R117P, R156P, R24PLi-Fraumeni syndrome, Hereditary cancer-predisposing syndromeUncertain significance
(Sep 10, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr17:7576900-7576909
GRCh38:
Chr17:7673582-7673591
TP53S181fs, S274fs, S154fs, S313fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
64.
GRCh37:
Chr17:7576852
GRCh38:
Chr17:7673534
TP53Li-Fraumeni syndromePathogenic
(Aug 9, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr17:7578379
GRCh38:
Chr17:7675061
TP53D184fs, D52fs, D145fs, D25fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
66.
GRCh37:
Chr17:7578239-7578240
GRCh38:
Chr17:7674921-7674922
TP53E204*, E45*, E72*, E165*Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
67.
GRCh37:
Chr17:7577046-7577050
GRCh38:
Chr17:7673728-7673732
TP53H257fs, H137fs, H164fs, H296fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
68.
GRCh37:
Chr17:7579419-7579420
GRCh38:
Chr17:7676101-7676102
TP53S51fs, S90fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
69.
GRCh37:
Chr17:7578195-7578197
GRCh38:
Chr17:7674877-7674879
TP53V59del, V218del, V86del, V179delNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
70.
GRCh37:
Chr17:7578456-7578459
GRCh38:
Chr17:7675138-7675141
TP53R158fs, R26fs, R119fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
71.
GRCh37:
Chr17:7578402-7578404
GRCh38:
Chr17:7675084-7675086
TP53C17R, C44R, C137R, C176RNeoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
72.
GRCh37:
Chr17:7579434-7579441
GRCh38:
Chr17:7676116-7676123
TP53A83fs, A44fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
73.
GRCh37:
Chr17:7578259
GRCh38:
Chr17:7674941
TP53V158E, V197E, V65E, V38EHereditary cancer-predisposing syndrome, Li-Fraumeni syndromeUncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr17:7577586
GRCh38:
Chr17:7674268
TP53I100S, I193S, I232S, I73SHereditary cancer-predisposing syndromePathogenic
(Mar 28, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr17:7577082
GRCh38:
Chr17:7673764
TP53E154*, E247*, E286*, E127*Li-Fraumeni syndromePathogenic
(Sep 1, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr17:7578188
GRCh38:
Chr17:7674870
TP53E182*, E221*, E89*, E62*Li-Fraumeni syndromePathogenic
(Jul 26, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr17:7579346
GRCh38:
Chr17:7676028
TP53L114*, L75*Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
78.
GRCh37:
Chr17:7578176
GRCh38:
Chr17:7674858
TP53Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
79.
GRCh37:
Chr17:7573993-7574000
GRCh38:
Chr17:7670675-7670682
TP53Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
80.
GRCh37:
Chr17:7579417-7579427
GRCh38:
Chr17:7676099-7676109
TP53P87fs, P48fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
81.
GRCh37:
Chr17:7577128
GRCh38:
Chr17:7673810
TP53F138fs, F231fs, F111fs, F270fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
82.
GRCh37:
Chr17:7579462-7579463
GRCh38:
Chr17:7676144-7676145
TP53A37fs, A76fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
83.
GRCh37:
Chr17:7577098
GRCh38:
Chr17:7673780
TP53R148S, R241S, R280S, R121SHereditary cancer-predisposing syndromeUncertain significance
(May 11, 2020)
criteria provided, single submitter
84.
GRCh37:
Chr17:56809906
GRCh38:
Chr17:58732545
RAD51CNeoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
85.
GRCh37:
Chr2:47705467-47705468
GRCh38:
Chr2:47478328-47478329
MSH2Hereditary cancer-predisposing syndromePathogenic
(Oct 8, 2020)
criteria provided, single submitter
86.
GRCh37:
Chr17:41243455
GRCh38:
Chr17:43091438
LOC126862571, BRCA1L1365V, L1318V, L1277V, L1297V, L1338V, L1069V, L1237V, L1253V, L1294V, L1323V, L497V, L1254V, L1298V, L1324V, L1362V, L1197V, L1238V, L1276V, L1295V, L1317V, L1339V, L1364VHereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Mar 23, 2023)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr17:41245645-41245646
GRCh38:
Chr17:43093628-43093629
BRCA1N588*, N635*, N339*, N467*, N507*, N508*, N594*, N608*, N609*, N634*, N546*, N564*, N567*, N587*, N523*, N565*, N568*, N593*, N632*, N524*, N547*Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
88.
BRCA1Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
89.
BRCA1Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
90.
BRCA1Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
91.
GRCh37:
Chr17:41256234
GRCh38:
Chr17:43104217
BRCA1E116*, E69*, E46*, E72*, E90*, E113*Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
92.
GRCh37:
Chr2:48026613-48026641
GRCh38:
Chr2:47799474-47799502
MSH6K196fs, K498fs, K368fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
93.
GRCh37:
Chr10:89725051-89725067
GRCh38:
Chr10:87965294-87965310
PTENL148fs, L345fs, L518fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
94.
GRCh37:
Chr2:215645284
GRCh38:
Chr2:214780560
BARD1K438N, K419NNeoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
95.
GRCh37:
Chr17:41246246-41246247
GRCh38:
Chr17:43094229-43094230
BRCA1S434fs, S387fs, S307fs, S323fs, S346fs, S392fs, S407fs, S408fs, S138fs, S363fs, S366fs, S367fs, S364fs, S386fs, S431fs, S266fs, S306fs, S322fs, S345fs, S393fs, S433fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
96.
GRCh37:
Chr17:33434384
GRCh38:
Chr17:35107365
RAD51D, RAD51L3-RFFLNeoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
97.
GRCh37:
Chr5:56177536-56177547
GRCh38:
Chr5:56881709-56881720
MAP3K1Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
98.
GRCh37:
Chr2:48027958
GRCh38:
Chr2:47800819
MSH6E946*, E816*, E644*Hereditary cancer-predisposing syndromePathogenic
(Jan 3, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr13:32971183
GRCh38:
Chr13:32397046
BRCA2Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
100.
GRCh37:
Chr17:41244452
GRCh38:
Chr17:43092435
BRCA1E986fs, E1033fs, E1006fs, E906fs, E965fs, E966fs, E944fs, E962fs, E1032fs, E737fs, E905fs, E921fs, E963fs, E985fs, E1007fs, E1030fs, E865fs, E922fs, E945fs, E991fs, E992fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination